Theravance Biopharma, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TBPH Nasdaq 2836 www.theravance.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Theravance Biopharma, Inc.

Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 10th, 2026 6:30 am
electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2026 5:10 pm
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results - Aug 6th, 2026 2:05 pm
Ocular Therapeutix (OCUL) Reports Q2 Loss, Beats Revenue Estimates - Aug 3rd, 2026 6:10 am
Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates - Jul 30th, 2026 3:15 pm
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026 - Jul 16th, 2026 4:00 am
Zymeworks (ZYME) Stock Looks Fully Valued Despite Its 205% Three Year Run - Jul 1st, 2026 4:10 am
Zymeworks agrees to buy Theravance Biopharma for $929m - Jun 30th, 2026 2:26 am
Sector Update: Healthcare Stocks Higher Late Afternoon - Jun 29th, 2026 1:59 pm
Zymeworks To Buy Theravance Biopharma In $929M Deal – A Look At What This Deal Means For TBPH Shareholders - Jun 29th, 2026 6:44 am
Zymeworks to Buy Theravance for Lung Disease Drug. Both Stocks Are Sliding. - Jun 29th, 2026 6:39 am
Zymeworks to Acquire Theravance Biopharma in $929 Million Deal - Jun 29th, 2026 4:19 am
THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT - Jun 29th, 2026 4:00 am
Zymeworks to Acquire Theravance Biopharma, Inc. - Jun 29th, 2026 4:00 am
Theravance, after clinical setbacks, agrees to $929M buyout - Jun 29th, 2026 2:42 am
Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains? - Jun 25th, 2026 5:48 am
Are Options Traders Betting on a Big Move in Theravance Biopharma Stock? - May 13th, 2026 7:27 am
Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update - May 7th, 2026 6:30 am